Healthcare -
Biotechnology - NASDAQ - US
$ 1.135
-12 %
$ 4.72 M
Market Cap
-0.09
P/E
MBRX - STOCK-BASED COMPENSATION
Stock-based Compensation MBRX - Moleculin Biotech, Inc.
1.98 M
LAST VALUE
-8.56%
2 YEAR CAGR
11.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR